MCLR logo

Medclair AB Stock Price

NGM:MCLR Community·SEK 234.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

MCLR Share Price Performance

SEK 0
-1.31 (-100.00%)
SEK 0
-1.31 (-100.00%)
Price SEK 0

MCLR Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with questionable track record.

2 Risks
2 Rewards

Medclair AB Key Details

SEK 49.7m

Revenue

SEK 14.2m

Cost of Revenue

SEK 35.5m

Gross Profit

SEK 30.3m

Other Expenses

SEK 5.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.063
71.35%
10.50%
0%
View Full Analysis

About MCLR

Founded
2008
Employees
14
CEO
Jonas Lundh
WebsiteView website
www.medclair.com

Medclair AB, a research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O). It offers mobile destruction unit, a solution that can be moved anywhere, where N2O is needed for pain relief; central destruction unit, a system designed for larger N2O destruction volumes; exhalation device that addresses the problem with residual levels of N2O in the patient’s exhalation; collection units for non-frequent use of N2O, and less frequent use or fitting in emergency services vehicles; and Nitrous Oxide Detector, an N2O measuring device for detecting the levels of N2O in the air. The company serves maternity wards, children’s healthcare, and dental care facilities. Medclair AB was incorporated in 2008 and is based in Stockholm, Sweden.

Recent MCLR News & Updates

Recent updates

No updates